Browse > Article

Tingling Sensation and Difficulty in Daily Living of Clients Treated FOLFOX Chemotherapy after Colon Resection  

Lee, Hye-Seon (Department of Nursing, Inje University Paik Hospital)
Kim, Myung-Hee (College of Nursing, Pusan National University)
Kang, Eun-Hee (College of Nursing, Pusan National University)
Publication Information
The Korean Journal of Rehabilitation Nursing / v.13, no.2, 2010 , pp. 97-104 More about this Journal
Abstract
Purpose: This study was to investigate difficulties in daily activities and tingling from patients having treatment of FOLFOX chemotherapy after colon resection. Method: This study included 103 patients hospitalized for FOLFOX chemotherapy in one of the university affiliated hospital from August 1, 2008 through September 30, 2009. Data were collected using the questionnaire comprised general symptoms, tingling, difficulties in daily activities and coping behavior. Using the SPSS 14.0 program, data analytic methods include Chi-Square test, ANOVA, Scheffe's test. Results: The tingling sensation occurred in hands, feet, mouth, throat. Contacts with cold objects and the number of chemotherapy cycle worsen tingling sensation. Patients experienced difficulties in daily activities such as personal hygiene, kitchen work, eating cold food, sleeping cold, using fine motors like button up, writing, or using knife. The coping behavior included drinking warm water, sleeping warm, using gloves and socks, wearing comfortable shoes, massaging hands and getting help from supporters. Conclusion: An educational guideline for promoting coping behavior to relieve tingling sensation and difficulty in daily living in patients with FOLFOX chemotherapy is needed.
Keywords
FOLFOX protocol; Activities of daily living; Sensation;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Statistics Korea. (2009). Cause of death. Retrieved October 21, 2009, from http://www.kostat.go.kr/
2 Wiseman, L. R., Adkins, J. C., Plosker, G. L., & Goa, K. L. (1999). Oxaliplatin: A review of its use in the management of metastatic colorectal cancer. Drugs & Aging, 14, 459-475.   DOI   ScienceOn
3 McCorkle, R., & Young, K. (1978). Development of a symptom distress scale. Cancer Nursing, 1, 373-378.
4 Park, M. H. (2003). Analysis of Oxaliplatin and Irinotecan combined with Fluorouracil as second-line treatment in patient with progressive, metastatic coloretal cancer after 5-FU regimen failure. Unpublished master's thesis, Sookmyung Women's University, Seoul.
5 Giacchetti, S., Perpoint, B., Zidani, R., Le Bail, N., Faggiuolo, R., & Focan, C., et al. (2000). Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology, 18, 136-147.
6 Hong, G. P., Kang, H. S., Oh, S. Y., Im, N. Y., Kim, J. I., & Yoo, M. S., et al. (2000). Basic nursing II. Seoul: Soomoonsa.
7 Kim, H. J. (1997). Cancer patients' use of self-care behaviors in managing side effects related to chemotherapy. Unpublished master's thesis, Chung-Ang University, Seoul.
8 Kim, J. E. (2009). The family support and the management of side effects from chemotherapy for female cancer patients. Unpublished master's thesis, Ewha Womans University, Seoul.
9 Park, Y. S. (2007). Recent advances in treatment of colon cancer. Journal of the Korean Academy of Family Medicine, 28, 302-305.
10 Yu, S. M., & Gu, M. O. (2003). A study on nausea & vomiting, anorexia and food intake in cancer patients undergoing chemotherapy overtime. Journal of Korean Academy of Adult Nursing, 15, 573-585.
11 Raymond, E., Chaney, S. G., Taamma, A., & Cvitkovic, E. (1998). Oxaliplatin: A review of preclinical and clinical studies. Annals of Oncology, 9, 1053-1071.   DOI   ScienceOn
12 Kim, Y. K. (2007). Side effects of chemotherapy for gastrointestinal cancer patients who visited in ER. Unpublished master's thesis, Ewha Womans University, Seoul.
13 Lee, J. E. (2005). Symptom experiences according to chemotherapy cycle in patients with breast cancer. Unpublished master's thesis, Yonsei University, Seoul.
14 Lee, M. R. (2006). The effects of personal education on prevention of oral mucositis and self care performance for cancer patients receiving cancer chemotherapy. Unpublished master's thesis, Yonsei University, Seoul.
15 De Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., & Cassidy, J., et al. (2000). Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology, 18, 2938-2947.
16 Gamelin, L., Boisdron-Celle, M., Morel, A., Poirier, A. L., Berger, V., & Gamelin, E., et al. (2008). Oxaliplatinrelated neurotoxicity: Interest of calcium-magnesium infusion and no impact on its efficacy. Journal of Clinical Oncology, 26, 1189-1190.
17 Saif, M. W., & Reardon, J. (2005) Management of oxaliplatininduced peripheral neuropathy. Therapeutics and Clinical Risk Management, 1, 249-258.
18 Shin, J. H., Kim, S. Y., Woo, C. M., Kim, Y. S., Kim, J. Y., & Seo, J. H., et al. (2004). Oxaliplatin and UFT, leucovorin combination chemotherapy in patients with advanced colorectal cancer. Korean Journal of Medicine, 67, 58-64.
19 Suh, C. W., Kim, S. Y., Bang, Y. J., Kim, N. K., Park, J. G., & Lee, K. U., et al. (1988). 5-Fluorouracil infusion and Cisplatin (FP) combination chemotherapy for metastatic or recurrent colorectal cancer. Korean Journal of Medicine, 35, 464-470.
20 Lee, J. H., Park, S. J., Park, S. E., Kwak, S. K., Shin, H. Y., & Kim, S. E., et al. (2001). The efficacy of combination chemotherapy of 5-fluorouracil, leucovorin, oxaliplatin, on relapsed or refractory colorectal cancer. Chungnam Medical Journal, 28, 277-287.
21 Kim, M. J. (2007). Side effects and coping methods in patients receiving chemotherapy for treatment of stomach cancer. Unpublished master's thesis, Hanyang University, Seoul.
22 Kim, Y. J., & Kim, H. D. (2004). New trend in chemotherapy for colorectal cancer. Journal of the Korean Society of Coloproctology, 20, 118-123.
23 An, B. M. (2005). Outpatient basis chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as first-line treatment for patients with metastatic or recurrent colorectal cancer. Unpublished master's thesis, Kyungpook National University, Daegu.
24 Bang, S. M., Cho, E. K., Oh, J. H., Chang, H. M., Ahn, J. S., & Rhee, J. A., et al. (2001). Combination chemotheapy of oxaliplatin, 5-fluorouracil, and leucovorin in 5-fluorouracil-pretreated patients with metastatic colorectal cancer. Journal of Korean Cancer Research Association, 33, 414-419.